fluorouracil has been researched along with Cystadenocarcinoma in 28 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Cystadenocarcinoma: A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intraperitoneal chemotherapy with mitomycin C and 5-fluorouracil has been used to rescue patients from peritoneal carcinomatosis after perforated cystadenocarcinoma of the large bowel or appendix." | 7.68 | Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix. ( Jaffe, G; Landy, D; Pascal, R; Sugarbaker, PH, 1990) |
| "Intraperitoneal chemotherapy with mitomycin C and 5-fluorouracil has been used to rescue patients from peritoneal carcinomatosis after perforated cystadenocarcinoma of the large bowel or appendix." | 3.68 | Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix. ( Jaffe, G; Landy, D; Pascal, R; Sugarbaker, PH, 1990) |
| " Except for melatonin, all neuroendocrine hormones used in this study inhibited proliferation of KF cells derived from human serous cystadenocarcinoma of the ovary in a dose-dependent manner." | 3.67 | Inhibition of human ovarian cancer cell proliferation in vitro by neuroendocrine hormones. ( Iwano, I; Kato, K; Kikuchi, Y; Kita, T; Miyauchi, M, 1989) |
| " Other adverse sequelae, such as abdominal pain, were manageable with medication." | 1.28 | Adverse effects of intraperitoneal fluorouracil in patients with optimal residual ovarian cancer after second-look laparotomy: a Gynecologic Oncology Group Study. ( Blessing, JA; Homesley, HD; Walton, LA, 1989) |
| "A case of brain metastasis in ovarian cancer is reported." | 1.27 | [Metastatic brain tumor after chemotherapy of ovarian cancer]. ( Chen, JT; Fujimoto, I; Fukuda, K; Hasumi, K; Masubuchi, K; Sakamoto, A; Yamauchi, K, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (75.00) | 18.7374 |
| 1990's | 6 (21.43) | 18.2507 |
| 2000's | 1 (3.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iyama, S | 1 |
| Takahashi, Y | 1 |
| Shintani, N | 1 |
| Fujikawa, K | 1 |
| Ohkubo, S | 1 |
| Sato, Y | 2 |
| Sato, T | 1 |
| Ohnuma, K | 1 |
| Niitsu, Y | 1 |
| Scarabelli, C | 1 |
| Campagnutta, E | 1 |
| Benedetti Panici, P | 1 |
| Di Roberto, P | 1 |
| Margariti, PA | 1 |
| Villani, L | 1 |
| Sacco, F | 1 |
| Cognetti, F | 1 |
| Bompiani, A | 1 |
| Hashimi, LA | 1 |
| Khalyl, MF | 1 |
| Salem, PA | 1 |
| Yoshizawa, H | 1 |
| Kanazawa, K | 1 |
| Takeuchi, S | 1 |
| Okamura, Y | 1 |
| Goto, S | 1 |
| Kajiwara, T | 1 |
| Nuutinen, LS | 1 |
| Kauppila, A | 1 |
| Ryhänen, P | 1 |
| Niinimäki, A | 1 |
| Kivinen, S | 1 |
| Saarela, M | 1 |
| Pakarinen, A | 1 |
| Hollmén, A | 1 |
| Rózewicki, S | 1 |
| Rzepka, I | 1 |
| Górski, H | 1 |
| Ogorodnikova, IS | 1 |
| Zubkova, TV | 1 |
| Gaĭrabed'iants, NG | 1 |
| Frank, S | 1 |
| Richter, K | 1 |
| Ehrhart, H | 1 |
| Penning, W | 1 |
| Meister, P | 1 |
| Schmidt, D | 1 |
| Götz, A | 1 |
| Wu, JZ | 1 |
| Dempke, WC | 1 |
| Hosking, LK | 1 |
| Hill, BT | 1 |
| Gebbia, V | 1 |
| Russo, A | 1 |
| Gebbia, N | 1 |
| Rausa, L | 1 |
| Ingria, F | 1 |
| Spatafora, G | 1 |
| Zerillo, G | 1 |
| Cimino, A | 1 |
| Pastorello, T | 1 |
| Ferrara, P | 1 |
| Novikova, EG | 1 |
| Borisov, VI | 1 |
| Dmitriev, DG | 1 |
| Zel'vin, BM | 1 |
| Karseladze, AI | 1 |
| Shchitkov, KG | 1 |
| Li, AD | 1 |
| Sugarbaker, PH | 1 |
| Landy, D | 1 |
| Jaffe, G | 1 |
| Pascal, R | 1 |
| Wood, D | 1 |
| Silberman, AW | 1 |
| Heifetz, L | 1 |
| Memsic, L | 1 |
| Shabot, MM | 1 |
| Tanaka, Y | 1 |
| Ueda, G | 1 |
| Tanizawa, O | 1 |
| Miyake, H | 1 |
| Kohno, M | 1 |
| Nishiyama, S | 1 |
| Inoue, H | 1 |
| Ikeuchi, H | 1 |
| Sekigawa, S | 1 |
| Matsunaga, S | 1 |
| Kikuchi, Y | 1 |
| Kita, T | 1 |
| Miyauchi, M | 1 |
| Iwano, I | 1 |
| Kato, K | 1 |
| Walton, LA | 1 |
| Blessing, JA | 1 |
| Homesley, HD | 1 |
| Barlow, JJ | 1 |
| Lele, SB | 1 |
| Emrich, LJ | 1 |
| Fukuda, K | 1 |
| Chen, JT | 1 |
| Fujimoto, I | 1 |
| Yamauchi, K | 1 |
| Hasumi, K | 1 |
| Masubuchi, K | 1 |
| Sakamoto, A | 1 |
| Theissig, P | 1 |
| Theissig, F | 1 |
| Lotze, W | 1 |
| Paule, B | 1 |
| Frydman, R | 1 |
| Chasseray, JM | 1 |
| Schein, PS | 1 |
| Smith, JP | 3 |
| Rutledge, F | 2 |
| Speckhard, ME | 1 |
| Hurley, JD | 1 |
| Fetherston, WC | 1 |
| Grueninger, AJ | 1 |
| Wharton, JT | 1 |
| Rutledge, FN | 1 |
| Baer, JW | 1 |
2 reviews available for fluorouracil and Cystadenocarcinoma
| Article | Year |
|---|---|
[A case of recurrent biliary cystadenocarcinoma successfully treated with 5FU/CDDP systemic chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cisplatin; Cystadenocarcino | 2006 |
Chemotherapy in advanced ovarian cancer.
Topics: Adenocarcinoma; Adult; Aged; Alkylating Agents; Antineoplastic Agents; Cystadenocarcinoma; Cystadeno | 1973 |
3 trials available for fluorouracil and Cystadenocarcinoma
| Article | Year |
|---|---|
[Clinical trial of cisplatin in the treatment of ovarian carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Cystadenocarcino | 1982 |
Intensified nutrition as an adjunct to cytotoxic chemotherapy in gynaecological cancer patients.
Topics: Antineoplastic Agents; Body Weight; Cisplatin; Cyclophosphamide; Cystadenocarcinoma; Doxorubicin; Dr | 1982 |
Long-term survival rates with various chemotherapeutic regimens in stages III and IV ovarian adenocarcinoma. The influence of optimum pretreatment surgical resection.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 1985 |
23 other studies available for fluorouracil and Cystadenocarcinoma
| Article | Year |
|---|---|
Intraarterial infusion chemotherapy in the treatment of liver metastases from ovarian cancer.
Topics: Antineoplastic Agents; Cystadenocarcinoma; Doxorubicin; Drug Therapy, Combination; Endometriosis; Fe | 1981 |
The treatment of 48 patients affected by ovarian carcinoma at stages III and IV F.I.G.O.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Cyclophosphamide; Cystadenocarcinoma; Female; Fluorouracil; H | 1981 |
Supraventricular tachycardia. A probable complication of platinum treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cystadenocarcinoma; Dox | 1984 |
[Early results of polychemotherapy in advanced ovarian tumors].
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Adult; Aged; Carcinoma, Papillary; Cyclophosphamide; Cyst | 1979 |
[Ultrastructural changes in ovarian tumor cancer cells under the influence of preoperative chemotherapy].
Topics: Cell Nucleolus; Chromatin; Cystadenocarcinoma; Female; Fluorouracil; Humans; Mitochondria; Ovarian N | 1976 |
[1st report on programmed chemotherapy of ovarian carcinoma].
Topics: Adenocarcinoma; Antineoplastic Agents; Cyclophosphamide; Cystadenocarcinoma; Cystadenoma; Drug Thera | 1975 |
[Chemosensitivity testing of adenocystic tongue and gingival cancer cell lines].
Topics: Antineoplastic Agents; Cystadenocarcinoma; Doxorubicin; Drug Screening Assays, Antitumor; Fluorourac | 1992 |
Expression of collateral sensitivity to cisplatin, methotrexate, and fluorouracil in a human ovarian carcinoma cell line following exposure to fractionated x-irradiation in vitro.
Topics: Cisplatin; Combined Modality Therapy; Cystadenocarcinoma; Drug Resistance; Female; Fluorouracil; Glu | 1992 |
High-dose folinic acid and 5-fluorouracil plus cisplatin on a weekly schedule in the treatment of advanced cancer of the head and neck.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; | 1992 |
[Polymer-drug complexes in the treatment of extensive ovarian cancer].
Topics: Adult; Cellulose; Cyclophosphamide; Cystadenocarcinoma; Doxorubicin; Evaluation Studies as Topic; Fe | 1991 |
Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal Neoplasms; Colonic Neoplasm | 1990 |
Cystadenocarcinoma of the pancreas: neo-adjuvant therapy and CEA monitoring.
Topics: Carcinoembryonic Antigen; Combined Modality Therapy; Cystadenocarcinoma; Fluorouracil; Humans; Male; | 1990 |
[A case of amylase-producing ovarian tumor].
Topics: Amylases; Antineoplastic Combined Chemotherapy Protocols; Cystadenocarcinoma; Cytarabine; Female; Fl | 1986 |
Inhibition of human ovarian cancer cell proliferation in vitro by neuroendocrine hormones.
Topics: beta-Endorphin; Cell Division; Cystadenocarcinoma; DNA, Neoplasm; Dose-Response Relationship, Drug; | 1989 |
Adverse effects of intraperitoneal fluorouracil in patients with optimal residual ovarian cancer after second-look laparotomy: a Gynecologic Oncology Group Study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; | 1989 |
[Metastatic brain tumor after chemotherapy of ovarian cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cisplatin; Cyclop | 1987 |
[Rare late metastasis of a successfully treated advanced ovarian cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cyclopho | 1986 |
Multimodal approach to the treatment of stage III ovarian carcinoma: preliminary report of a pilot study and critical review.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; C | 1985 |
Chemotherapy in the treatment of cancer of the ovary.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Cyclophosphamide; Cystadenocarcinoma; Dactinomycin; Female | 1970 |
Integrated therapy in the treatment of ovarian cancer with surgery, radiation and chemotherapy.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Ascites; Chlorambucil; Cobalt Isotopes; Cyclophosphamide; | 1972 |
Chemotherapy of ovarian cancer. New approaches to treatment.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Antineoplastic Agents; Cyclophosphamide; Cystadenocarcinom | 1972 |
Metastatic ovarian cancer.
Topics: Adenocarcinoma, Mucinous; Cyclophosphamide; Cystadenocarcinoma; Dactinomycin; Drug Combinations; Fem | 1973 |
An unusual case of adenocarcinoma of the pancreas.
Topics: Adenocarcinoma, Mucinous; Adult; Antibiotics, Antineoplastic; Aorta, Abdominal; Calcinosis; Cystaden | 1974 |